Patents by Inventor Rami Burstein

Rami Burstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11907935
    Abstract: A system and method for reducing blockchain transaction delay are disclosed. The system consists of a trusted coin wallet framework that implements a trusted execution environment to initiate currency transactions between two clients. The trusted coin wallet framework includes an API proxy and a trusted shadow wallet. The method used by the trusted coin wallet framework involves interaction between the trusted shadow wallet and a peer trusted wallet owned by the other client, via the API proxy, from within the trusted execution environment. During these operations, the blockchain infrastructure is independently validating the transaction.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: February 20, 2024
    Assignee: Intel Corporation
    Inventors: Oleg Pogorelik, Guy Itzhaki, Rami Burstein
  • Publication number: 20240009420
    Abstract: The present disclosure generally relates, in certain embodiments, to light-based treatments. In some case, a subject having or at risk for a condition such as insomnia can be treated, e.g., with light, such as green light. Other conditions include sleep disorders such as sleep apnea and other indications. In some cases, the light that is administered to the subject may be green light, or the light may have a characteristic wavelength only in a wavelength range between 510 nm and 550 nm with a bandwidth no larger than 20 nm full-width-half-maximum. Other embodiments described herein are generally directed to systems for treating such conditions, kits for treating such conditions, or the like.
    Type: Application
    Filed: November 12, 2021
    Publication date: January 11, 2024
    Applicants: Haven Technologies Inc., Beth Israel Deaconess Medical Center, Inc.
    Inventors: Rami Burstein, Mark Severs, Jeff Sheely, Ajay Shashidar Kori
  • Publication number: 20230303674
    Abstract: The present invention relates to methods for selecting a headache patient responsive to treatment with an anti-CGRP antibody and to methods for reducing headache frequency in the selected patient comprising administering an anti-CGRP antibody.
    Type: Application
    Filed: June 9, 2023
    Publication date: September 28, 2023
    Inventor: Rami BURSTEIN
  • Patent number: 11718664
    Abstract: The present invention relates to methods for selecting a headache patient responsive to treatment with an anti-CGRP antibody and to methods for reducing headache frequency in the selected patient comprising administering an anti-CGRP antibody.
    Type: Grant
    Filed: August 18, 2020
    Date of Patent: August 8, 2023
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventor: Rami Burstein
  • Publication number: 20230210963
    Abstract: Provided is an invention based on methods to treat or prevent headaches with injectable compositions comprising botulinum toxin that may be administered using an injection paradigm that provides botulinum toxin at one or more locations of neuronal activity associated with EEG detectable brain cortical electrical activity to a subject suffering from such malady. Co-therapuetics therewith are also disclosed.
    Type: Application
    Filed: March 18, 2021
    Publication date: July 6, 2023
    Inventors: Mahan Chehrenama, Stephen Silberstein, Rami Burstein, Peter McAllister, Paul Matthew, Andrew Blumenfeld, Jessica Ailani, David Dodick, Roman Rubio
  • Publication number: 20230147214
    Abstract: Methods for treating seizures and for inhibiting progression of a focal seizure to a generalized seizure by administering extracranially a Clostridial derivative are described.
    Type: Application
    Filed: August 16, 2022
    Publication date: May 11, 2023
    Inventors: Rami Burstein, Agustin Melo Carrillo, Mitchell F. Brin
  • Patent number: 11497885
    Abstract: Apparatus and methods for producing narrow-band radiation in the green region of the visible spectrum are described. The narrow-band radiation may be used to aid subjects experiencing photophobia. In some cases, subjects may experience a reduction in pain (e.g., migraine photophobia) when using the narrow-band radiation.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: November 15, 2022
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventor: Rami Burstein
  • Publication number: 20210398107
    Abstract: A system and method for reducing blockchain transaction delay are disclosed. The system consists of a trusted coin wallet framework that implements a trusted execution environment to initiate currency transactions between two clients. The trusted coin wallet framework includes an API proxy and a trusted shadow wallet. The method used by the trusted coin wallet framework involves interaction between the trusted shadow wallet and a peer trusted wallet owned by the other client, via the API proxy, from within the trusted execution environment. During these operations, the blockchain infrastructure is independently validating the transaction.
    Type: Application
    Filed: September 1, 2021
    Publication date: December 23, 2021
    Applicant: INTEL CORPORATION
    Inventors: Oleg Pogorelik, Guy Itzhaki, Rami Burstein
  • Patent number: 11127000
    Abstract: A system and method for reducing blockchain transaction delay are disclosed. The system consists of a trusted coin wallet framework that implements a trusted execution environment to initiate currency transactions between two clients. The trusted coin wallet framework includes an API proxy and a trusted shadow wallet. The method used by the trusted coin wallet framework involves interaction between the trusted shadow wallet and a peer trusted wallet owned by the other client, via the API proxy, from within the trusted execution environment. During these operations, the blockchain infrastructure is independently validating the transaction.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: September 21, 2021
    Assignee: INTEL CORPORATION
    Inventors: Oleg Pogorelik, Guy Itzhaki, Rami Burstein
  • Publication number: 20210128724
    Abstract: Methods for the treatment and prevention of diseases and disorders associated with cortical spreading depression by administering a CGRP antagonist, a Clostridial derivative or combination thereof are described.
    Type: Application
    Filed: July 6, 2020
    Publication date: May 6, 2021
    Inventors: Rami Burstein, Agustin Melo Carrillo, Mitchell F. Brin, Andrew M. Blumenfeld
  • Publication number: 20210085695
    Abstract: The present invention is related to compositions and methods for treating or reducing the likelihood of a migraine, reducing the severity of migraine, reducing the frequency of migraines, reducing the duration of migraine, and ameliorating the symptoms of a migraine. The methods and compositions of the present invention may also be used to treat or prevent condition characterized by increased cardiovascular risk or endothelial dysfunction and musculoskeletal symptoms.
    Type: Application
    Filed: October 1, 2020
    Publication date: March 25, 2021
    Inventors: Rami BURSTEIN, Catherine BUETTNER
  • Publication number: 20210015908
    Abstract: Methods for treating seizures and for inhibiting progression of a focal seizure to a generalized seizure by administering extracranially a Clostridial derivative are described.
    Type: Application
    Filed: July 6, 2020
    Publication date: January 21, 2021
    Inventors: Rami Burstein, Agustin Melo Carrillo, Mitchell F. Brin
  • Publication number: 20200385449
    Abstract: The present invention relates to methods for selecting a headache patient responsive to treatment with an anti-CGRP antibody and to methods for reducing headache frequency in the selected patient comprising administering an anti-CGRP antibody.
    Type: Application
    Filed: August 18, 2020
    Publication date: December 10, 2020
    Inventor: Rami BURSTEIN
  • Patent number: 10806890
    Abstract: Apparatus and methods for producing narrow-band radiation in the green region of the visible spectrum are described. The narrow-band radiation may be used to aid subjects experiencing photophobia. In some cases, subjects may experience a reduction in pain (e.g., migraine photophobia) when using the narrow-band radiation.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: October 20, 2020
    Assignee: BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
    Inventor: Rami Burstein
  • Patent number: 10766952
    Abstract: The present invention relates to methods for selecting a headache patient responsive to treatment with an anti-CGRP antibody and to methods for reducing headache frequency in the selected patient comprising administering an anti-CGRP antibody.
    Type: Grant
    Filed: March 1, 2018
    Date of Patent: September 8, 2020
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventor: Rami Burstein
  • Publication number: 20200114117
    Abstract: Apparatus and methods for producing narrow-band radiation in the green region of the visible spectrum are described. The narrow-band radiation may be used to aid subjects experiencing photophobia. In some cases, subjects may experience a reduction in pain (e.g., migraine photophobia) when using the narrow-band radiation.
    Type: Application
    Filed: December 9, 2019
    Publication date: April 16, 2020
    Applicant: Beth Israel Deaconess Medical Center, Inc.
    Inventor: Rami Burstein
  • Publication number: 20190114626
    Abstract: A system and method for reducing blockchain transaction delay are disclosed. The system consists of a trusted coin wallet framework that implements a trusted execution environment to initiate currency transactions between two clients. The trusted coin wallet framework includes an API proxy and a trusted shadow wallet. The method used by the trusted coin wallet framework involves interaction between the trusted shadow wallet and a peer trusted wallet owned by the other client, via the API proxy, from within the trusted execution environment. During these operations, the blockchain infrastructure is independently validating the transaction.
    Type: Application
    Filed: December 17, 2018
    Publication date: April 18, 2019
    Inventors: Oleg Pogorelik, Guy Itzhaki, Rami Burstein
  • Publication number: 20190085061
    Abstract: The present invention relates to methods for selecting a headache patient responsive to treatment with an anti-CGRP antibody and to methods for reducing headache frequency in the selected patient comprising administering an anti-CGRP antibody.
    Type: Application
    Filed: March 1, 2018
    Publication date: March 21, 2019
    Inventor: Rami Burstein
  • Publication number: 20190071490
    Abstract: Disclosed herein are methods of preventing incidence of a migrainous or non-migrainous post-ictal headache, and/or at least one secondary symptom associated with a migrainous post-ictal headache in a subject comprising administering to the subject a monoclonal antibody that modulates the CGRP pathway. Compositions for use in the disclosed methods are also provided.
    Type: Application
    Filed: March 1, 2018
    Publication date: March 7, 2019
    Inventor: Rami Burstein
  • Publication number: 20180177976
    Abstract: Apparatus and methods for producing narrow-band radiation in the green region of the visible spectrum are described. The narrow-band radiation may be used to aid subjects experiencing photophobia. In some cases, subjects may experience a reduction in pain (e.g., migraine photophobia) when using the narrow-band radiation.
    Type: Application
    Filed: June 17, 2016
    Publication date: June 28, 2018
    Applicant: Beth Israel Deaconess Medical Center, Inc.
    Inventor: Rami Burstein